Company:  CELLULAR BIOMEDICINE GROU ... (CBMG)
Form Type:  4
Filing Date:  3/13/2018 
CIK:  0001378624 
Address:  19925 STEVENS CREEK BLVD., SUITE 100 
City, State, Zip:  CUPERTINO, California 95014 
Telephone:  (408) 973-7884 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$21.75  
Change: 
0.775 (3.70%)  
Trade Time: 
Sep 21  
Market Cap: 
$368.92M
Trade CBMG now with

© 2018  
Description of Business
As used in this annual report, "we", "us", "our", "CBMG", "Company" or "our company" refers to Cellular Biomedicine Group, Inc. and, unless the context otherwise requires, all of its subsidiaries or deemed controlled companies. Overview Cellular Biomedicine Group, Inc. is a clinical stage biopharmaceutical company, principally engaged in the development of therapies for cancer and degenerative diseases utilizing proprietary cell-based technologies. Our technology includes two major platforms: (i) Immune cell therapy for treatment of a broad range of cancer indications comprised of technologies in Chimeric Antigen Receptor modified T cells (CAR-T), T-Cell Receptor (TCR), cancer vaccine, and ex vivo expanded autologous Central Memory T Cells (Tcm), and (ii) human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    REPORTING OWNERS
    SIGNATURES